These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34326933)

  • 21. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil.
    Bobrovski VG; Pinheiro AL; de-Castro JAL; Rech EB; Zacarkim EV; Dos-S-Reis ES; Eger I
    Curr Probl Cardiol; 2024 Mar; 49(3):102340. PubMed ID: 38103813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    Vicaire H; Pavec JL; Mercier O; Montani D; Boucly A; Roche A; Pradère P; Dauriat G; Feuillet S; Pichon J; Jevnikar M; Beurnier A; Jaïs X; Fadel E; Sitbon O; Humbert M; Savale L
    J Heart Lung Transplant; 2022 Sep; 41(9):1285-1293. PubMed ID: 35778258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?
    Rosenzweig EB; Bacha E
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1150-1151. PubMed ID: 33334602
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiology of pulmonary arterial hypertension.
    Taichman DB; Mandel J
    Clin Chest Med; 2013 Dec; 34(4):619-37. PubMed ID: 24267294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex and gender in pulmonary arterial hypertension.
    Cheron C; McBride SA; Antigny F; Girerd B; Chouchana M; Chaumais MC; Jaïs X; Bertoletti L; Sitbon O; Weatherald J; Humbert M; Montani D
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34750113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
    Condon DF; Agarwal S; Chakraborty A; Auer N; Vazquez R; Patel H; Zamanian RT; de Jesus Perez VA
    Chest; 2022 Apr; 161(4):1060-1072. PubMed ID: 34655569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk stratification methods and their significance in pulmonary arterial hypertension].
    Avdeev SN; Tsareva NA
    Ter Arkh; 2019 Sep; 91(9):150-157. PubMed ID: 32598827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New and Emerging Therapies for Pulmonary Arterial Hypertension.
    Spiekerkoetter E; Kawut SM; de Jesus Perez VA
    Annu Rev Med; 2019 Jan; 70():45-59. PubMed ID: 30216732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
    Sobanski V; Launay D; Hachulla E; Humbert M
    Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment tools for survival prognosis: An era of new surrogacy endpoints for clinical outcome measurement in pulmonary arterial hypertension clinical trials?
    Sanna L; Todea A
    Respir Med Res; 2022 May; 81():100893. PubMed ID: 35523041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.
    Kanwar M; Raina A; Lohmueller L; Kraisangka J; Benza R
    Curr Hypertens Rep; 2019 Apr; 21(6):45. PubMed ID: 31025123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Drugs and Therapies in Pulmonary Arterial Hypertension.
    Shah AJ; Beckmann T; Vorla M; Kalra DK
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibilities of Magnetic Resonance Tomography in Diagnosis of Pulmonary Arterial Hypertension].
    Shariya AM; Martynyuk TV; Ternovoy SK; Shariya MA
    Kardiologiia; 2021 Jul; 61(6):97-104. PubMed ID: 34311693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The study of risk in pulmonary arterial hypertension.
    Rubin LJ; Simonneau G; Badesch D; Galiè N; Humbert M; Keogh A; Massaro J; Matucci Cerinic M; Sitbon O; Kymes S
    Eur Respir Rev; 2012 Sep; 21(125):234-8. PubMed ID: 22941888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
    Hoeper MM; Barberà JA; Channick RN; Hassoun PM; Lang IM; Manes A; Martinez FJ; Naeije R; Olschewski H; Pepke-Zaba J; Redfield MM; Robbins IM; Souza R; Torbicki A; McGoon M
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S85-S96. PubMed ID: 19555862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in pulmonary hypertension diagnosis and risk stratification].
    Maloir Q; Petitjean H; Parzibut G; Weber T; Davidsen C; Dulgheru E; Lancellotti P; Louis R; Guiot J; Humbert M
    Rev Med Liege; 2023 Feb; 78(2):99-106. PubMed ID: 36799327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Top End Pulmonary Hypertension Study: Understanding Epidemiology, Therapeutic Gaps and Prognosis in Remote Australian Setting.
    Naing P; Playford D; Strange G; Abeyaratne A; Berhane T; Joseph S; Costelloe E; Hall M; Scalia GM; Forrester DL; Falhammar H; Kangaharan N
    Heart Lung Circ; 2021 Apr; 30(4):507-515. PubMed ID: 32962944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease.
    Arshad HB; Duarte VE
    Methodist Debakey Cardiovasc J; 2021; 17(2):145-151. PubMed ID: 34326934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.